vTv Therapeutics Inc. said it raised $2.5 million from the sale of 570,776 class A common shares to its investor, MacAndrews & Forbes Group LLC.
The sale was made under a letter agreement between the company and the investor dated Dec. 5, 2017.
vTv Therapeutics raises $2.5M from sale of common shares
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
vTv Therapeutics Inc. said it raised $2.5 million from the sale of 570,776 class A common shares to its investor, MacAndrews & Forbes Group LLC.
The sale was made under a letter agreement between the company and the investor dated Dec. 5, 2017.